Shockingly, Pfizer has admitted the failings of its own medicine, recalling five lots of Accupril pills due to the existence of an organic compound that could lead to an increased risk of cancer.
According to WebMD, Accupril, more commonly known as Quinapril, is used to lower blood pressure to prevent strokes, heart attacks, and kidney problems and treat heart failure by relaxing blood vessels so blood can flow more easily.
The US FDA said Pfizer found the pills to have nitrosamine above the level acceptable for daily intake.
“Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time,” writes the FDA in an announcement.
The FDA continues, saying that to date, “Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall.”
However, by this point, there’s no way that Pfizer hasn’t been made aware of the millions of adverse event reports around the world due to COVID vaccines.
As reported by The Counter Signal, in the US alone in 2021, the CDC’s Vaccine Adverse Event Reporting System (VAERS) logged over one million adverse events, many of which are heart-related and may have been treated with Accupril.
Nonetheless, Pfizer apparently has no plans to issue a recall. Probably because the COVID vaccine is their best seller, resulting in a 92 per cent operational growth in revenue to $81.3 billion in 2021 compared to $41.7 billion in 2020.
As many will know, Pfizer has also been highly reluctant (to say the least) to release its trial documents that reveal all the devastating side effects of its product. Indeed, they initially tried to keep these results hidden for decades until being hit with a court order.
